FR2377416A1 - Nouveaux antigenes lies au carcinome du sein - Google Patents
Nouveaux antigenes lies au carcinome du seinInfo
- Publication number
- FR2377416A1 FR2377416A1 FR7800661A FR7800661A FR2377416A1 FR 2377416 A1 FR2377416 A1 FR 2377416A1 FR 7800661 A FR7800661 A FR 7800661A FR 7800661 A FR7800661 A FR 7800661A FR 2377416 A1 FR2377416 A1 FR 2377416A1
- Authority
- FR
- France
- Prior art keywords
- acs
- breast carcinoma
- new antigens
- incubate
- complexes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010006187 Breast cancer Diseases 0.000 title abstract 2
- 208000026310 Breast neoplasm Diseases 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 title abstract 2
- 102000036639 antigens Human genes 0.000 title abstract 2
- 108091007433 antigens Proteins 0.000 title abstract 2
- 201000008275 breast carcinoma Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000002381 plasma Anatomy 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/804—Radioisotope, e.g. radioimmunoassay
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/813—Cancer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/828—Cancer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
- Y10S530/83—Plasma; serum
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Oncology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Nouveaux antigènes liés au carcinome du sein Selon l'invention le procédé pour détecter l'ACS circulant dans le sérum sanguin ou le plasma implique d'effectuer les étapes suivantes : a. Ajouter une quantité spécifique d'antisérum anti-ACS à un échantillon sanguin, b. Faire incuber le mélange, c. Ajouter une quantité spécifique d'ACS étiqueté de manière radioactive, d. Faire incuber le mélange e. Séparer les complexes ACS-anti-ACS de l'ACS libre, f. Mesurer la radioactivité soit des complexes soit de l'ACS libre. Application à l'industrie pharmaceutique.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1140/77A GB1598811A (en) | 1977-01-12 | 1977-01-12 | Carcinoma-associated antigens |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2377416A1 true FR2377416A1 (fr) | 1978-08-11 |
FR2377416B1 FR2377416B1 (fr) | 1982-08-27 |
Family
ID=9716885
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7800661A Granted FR2377416A1 (fr) | 1977-01-12 | 1978-01-11 | Nouveaux antigenes lies au carcinome du sein |
Country Status (7)
Country | Link |
---|---|
US (1) | US4383985A (fr) |
JP (1) | JPS5388317A (fr) |
DE (1) | DE2801257A1 (fr) |
FR (1) | FR2377416A1 (fr) |
GB (1) | GB1598811A (fr) |
IT (1) | IT1143800B (fr) |
NL (1) | NL7800353A (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2489692A1 (fr) * | 1980-09-05 | 1982-03-12 | Univ Ramot | Procede de preparation d'un anticorps specifique pour le diagnostic precoce d'une affection maligne, mammaire, et l'anticorps obtenu |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4863853A (en) * | 1982-04-21 | 1989-09-05 | Bartos Patent Development And Holding Company Limited | Method of determining the diagnostic value of monitoring serum-CEA-levels in a carcinoma patient undergoing therapy |
US4818709A (en) * | 1983-01-21 | 1989-04-04 | Primus Frederick J | CEA-family antigens, Anti-CEA antibodies and CEA immunoassay |
US4565789A (en) * | 1983-04-04 | 1986-01-21 | The United States Of America As Represented By The Department Of Health And Human Services | Cell matrix receptor system and use in cancer diagnosis and management |
US4529693A (en) * | 1983-12-09 | 1985-07-16 | Children's Hospital Medical Center Of Northern California | Detecting neoplastic mammary epithelial cells by detecting thioesterase II marker |
JPS60214737A (ja) * | 1984-04-06 | 1985-10-28 | Nippon Koutai Kenkyusho:Kk | 糖鎖関連抗原の製造法 |
US4571276A (en) * | 1984-06-22 | 1986-02-18 | North American Philips Corporation | Method for strengthening terminations on reduction fired multilayer capacitors |
US5242823A (en) * | 1986-03-07 | 1993-09-07 | International Genetic Engineering, Inc. | Cloning of the 38kd Mycoplasma hyorhinis regression-associated antigen |
US4748112A (en) * | 1986-03-07 | 1988-05-31 | International Genetic Engineering, Inc. | Methods and compositions relating to regression-associated antigens |
US4785077A (en) * | 1986-05-05 | 1988-11-15 | Scripps Clinic And Research Foundation | Substantially pure cytotoxicity triggering factor |
US5030621A (en) * | 1987-04-23 | 1991-07-09 | Bystryn Jean Claude | Shed melanoma antigen compositions |
AU625858B2 (en) * | 1987-09-16 | 1992-07-16 | International Genetic Engineering, Inc. | Method and compositions relating to regression-associated antigens |
US5112617A (en) * | 1990-03-01 | 1992-05-12 | Criscuolo Pascual A | Method for controlling cold symptoms |
IT1244879B (it) * | 1990-12-11 | 1994-09-12 | Alberto Bartorelli | Estratti da tessuti animali, utili in terapia e in diagnostica. |
US5281700A (en) * | 1992-08-11 | 1994-01-25 | The Regents Of The University Of California | Method of recovering endothelial membrane from tissue and applications thereof |
US5728579A (en) * | 1994-08-11 | 1998-03-17 | President And Fellows Of Harvard College | DNA encoding Mat-8 |
US20030211971A1 (en) * | 2001-09-17 | 2003-11-13 | Srivastava Pramod K. | Compositions and methods for prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with compositions comprising unfractionated cellular proteins |
US7306919B1 (en) | 2001-10-31 | 2007-12-11 | Thornthwaite Jerry T | Antigen-antibody cancer recognition system |
US20060003391A1 (en) * | 2003-08-11 | 2006-01-05 | Ring Brian Z | Reagents and methods for use in cancer diagnosis, classification and therapy |
US20050112622A1 (en) * | 2003-08-11 | 2005-05-26 | Ring Brian Z. | Reagents and methods for use in cancer diagnosis, classification and therapy |
WO2005099363A2 (fr) | 2004-03-26 | 2005-10-27 | Whitehead Institute For Biomedical Research | Methodes de diagnostic, de prevention et de traitement de metastases cancereuses |
US8419434B2 (en) * | 2008-04-15 | 2013-04-16 | International Business Machines Corporation | Interactive recipe preparation using interactive cooking device to communicate with kitchen appliances |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2095728A5 (fr) * | 1970-06-01 | 1972-02-11 | Hoffmann La Roche | |
FR2323147A1 (fr) * | 1975-09-03 | 1977-04-01 | Eisai Co Ltd | Reactif de diagnose de neoplasme et procede de diagnose de neoplasme |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3410839A (en) * | 1964-04-16 | 1968-11-12 | Rand Dev Corp | Immunochromatographic partition of soluble antigens |
US3956258A (en) * | 1972-05-12 | 1976-05-11 | Hoffmann-La Roche Inc. | Carcinoembryonic antigens |
US3823126A (en) * | 1972-05-23 | 1974-07-09 | K Bjorklund | Process of separating human cancer antigen proteins by gel filtration |
US3960827A (en) * | 1972-07-10 | 1976-06-01 | Bjoerklund K B | Cancer associated polypeptide antigen, process for its preparation, process for preparing antibodies, process of cancer diagnosis and composition useful as an immunizing agent |
US4132769A (en) * | 1974-10-30 | 1979-01-02 | Osther Kurt B | Cancer antigen, cancer therapy, and cancer diagnosis |
-
1977
- 1977-01-12 GB GB1140/77A patent/GB1598811A/en not_active Expired
- 1977-12-30 IT IT31482/77A patent/IT1143800B/it active
-
1978
- 1978-01-10 JP JP94578A patent/JPS5388317A/ja active Pending
- 1978-01-11 FR FR7800661A patent/FR2377416A1/fr active Granted
- 1978-01-11 NL NL7800353A patent/NL7800353A/xx not_active Application Discontinuation
- 1978-01-12 DE DE19782801257 patent/DE2801257A1/de not_active Withdrawn
-
1980
- 1980-07-11 US US06/167,567 patent/US4383985A/en not_active Expired - Lifetime
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2095728A5 (fr) * | 1970-06-01 | 1972-02-11 | Hoffmann La Roche | |
FR2323147A1 (fr) * | 1975-09-03 | 1977-04-01 | Eisai Co Ltd | Reactif de diagnose de neoplasme et procede de diagnose de neoplasme |
Non-Patent Citations (2)
Title |
---|
CA1973 * |
EXBK/77 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2489692A1 (fr) * | 1980-09-05 | 1982-03-12 | Univ Ramot | Procede de preparation d'un anticorps specifique pour le diagnostic precoce d'une affection maligne, mammaire, et l'anticorps obtenu |
Also Published As
Publication number | Publication date |
---|---|
US4383985A (en) | 1983-05-17 |
JPS5388317A (en) | 1978-08-03 |
FR2377416B1 (fr) | 1982-08-27 |
IT1143800B (it) | 1986-10-22 |
NL7800353A (nl) | 1978-07-14 |
GB1598811A (en) | 1981-09-23 |
DE2801257A1 (de) | 1978-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2377416A1 (fr) | Nouveaux antigenes lies au carcinome du sein | |
Tatarinov et al. | Development of a radioimmunoassay for pregnancy‐specific beta1‐globulin and its measurement in serum of patients with trophoblastic and non‐trophoblastic tumours | |
FR2362397A1 (fr) | Procede radio-immunologique et dispositif servant a determiner les antigenes | |
Oroszlan et al. | Species-specific and interspecific antigenic determinants associated with the structural protein of feline C-type virus | |
Pressman et al. | A Comparison of Fluorescein and I131 as Labels for Determining the «in vivo» Localization of Anti-Tissue Antibodies | |
Aizawa et al. | Vasculitis and Sjögren's syndrome with IgA-IgG cryoglobulinemia terminating in immunoblastic sarcoma | |
Wallenius | A note on serum iron transportation | |
Olin et al. | Human fetal thyroglobulin: characterization and in vitro biosynthesis studies | |
Cullen et al. | Distribution of H-2 alloantigenic specificities on radiolabeled papain-solubilized antigen fragments | |
Wehler et al. | The use of solid phase Clq and horseradish peroxidase-conjugated goat anti-IgG for the detection of immune complexes in human serum | |
Hardwicke et al. | Human α1-glycoproteins Separation from pathological urine and examination by immunological and electrophoretic methods | |
Vriesman et al. | Ray γM immunoglobulin: Isolation and some biological characteristics | |
Kågedal et al. | Determination of thyroxine-binding globulin in human serum by single radial immunodiffusion and radioimmunoassay. | |
GB1564063A (en) | Process for the preparation of -l antibody and -l antigen and preparation and use of reagents containing them | |
Samols et al. | Studies of translatable mRNA for rabbit C-reactive protein | |
Fisher et al. | Studies of the butanol-extractable iodine technique by the ceric oxidation method | |
YUZURIHA et al. | Studies on biotransformation of lysozyme. I. Preparation of labeled lysozyme and its intestinal absorption | |
von der Decken | Labeling with 14C amino acids of albumin-like protein by rat liver ribonucleoprotein particles | |
Grundy et al. | Studies on Bile Acids in Rat Systemic Blood. Bile Acids and Steroids 107. | |
Sperti et al. | Competitive binding of adenine and nicotinamide–adenine dinucleotide to diphtheria toxin | |
Cuarón et al. | The binding of 131I-triiodothyronine by serum proteins as an in vitro test of thyroid function | |
Hansson et al. | Quantitation of corticosteroid binding globulin (CBG) by steady state polyacrylamide gel electrophoresis (SS-PAGE) | |
IT1132167B (it) | Metodo emolitico per la determinazione in continuo degli anticorpi antistreptolisina o,in campioni di sangue o di siero con impiego di streptolisina o ossidata | |
FR2416471A1 (fr) | Perfectionnement apporte a la reaction d'inhibition de l'hemo-agglutination des virus | |
Pirtle | Precipitation reactions in agar between swine serum and homologous pancreas extracts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |